Latest Dopamine Stories

redOrbit Staff & Wire Reports – Your Universe Online Some drugs used to treat ADHD could affect the brain's reward system, researchers from the University of Copenhagen have discovered. The findings make it easier to understand how the medicine works and could ultimately lead to improvements in the development of and the dose determination associated with ADHD treatments, they report in the latest edition of the Journal of Neurophysiology. As part of the study, Jakob Kisbye...

Alan McStravick for redOrbit.com - Your Universe Online Alzheimer’s is an degenerative illness that slowly robs the sufferer of their long-term memory and, through the resultant dementia, often leaves them lost and unable to discern between present and past. There is a reason that Alzheimer’s disease is referred to as “the long goodbye”. Led by Emrah Düzel, researchers from of the University of Magdeburg in Germany are studying the effects of the hormone dopamine and how it...

Brett Smith for redOrbit.com - Your Universe Online As any coffee drinker will tell you, the day immediately begins to feel better after taking that first earthy, faintly bitter sip o’ joe from the edge of a steaming cup. A new study from German researchers reinforces the positive aura swirling around the magical brown elixir as they have shown that caffeine can increase a person’s ability and speed in recognizing words with a positive connotation. The study also shows that the...

Scientists may have discovered why the standard treatment for Parkinson's disease is often effective for only a limited period of time. Their research could lead to a better understanding of many brain disorders, from drug addiction to depression, that share certain signaling molecules involved in modulating brain activity. A team led by Bernardo Sabatini, Takeda Professor of Neurobiology at Harvard Medical School, used mouse models to study dopamine neurons in the striatum, a region of...

SUNNYVALE, Calif., Oct. 25, 2012 /PRNewswire/ -- Amarantus BioSciences, Inc. (OTCQB: AMBS), a biotechnology company developing new disease-modifying treatments and diagnostics for Parkinson's disease and Traumatic Brain Injury centred on its proprietary anti-apoptosis therapeutic protein MANF, today announced that the Company has received positive behavioural efficacy data for MANF in a neurorestoration 6-hydroxydopamine (6-OHDA) rat model of Parkinson's disease. The data shows...

SUNNYVALE, Calif., Oct. 1, 2012 /PRNewswire/ -- Amarantus BioSciences, Inc. (OTCBB: AMBS), a biotechnology company developing new treatments for brain-related disorders including Parkinson's disease and Traumatic Brain Injuries (TBI) centered on its proprietary anti-apoptotic therapeutic protein known as MANF, today announced the publication of a landmark research paper on MANF, Amarantus' lead development program. The studies were conducted at the University of Helsinki, a research...

ROCHESTER, Minn., Sept. 20, 2012 /PRNewswire-USNewswire/ -- For far too many people, the symptoms are all-too familiar: uncomfortable, even painful, sensations in the legs while at rest. Tingling, twitching, throbbing or "antsy" feelings in the calves or thighs and even arms that make you want to get up, stretch, and move around. While these sensations can be hard to describe, the diagnosis isn't. It's called Restless Legs Syndrome (RLS/WED, or Willis-Ekbom disease) - and it affects...

People with Parkinson's disease performed markedly better on a test of working memory after a night's sleep, and sleep disorders can interfere with that benefit, researchers have shown. While the classic symptoms of Parkinson's disease include tremors and slow movements, Parkinson's can also affect someone's memory, including "working memory." Working memory is defined as the ability to temporarily store and manipulate information, rather than simply repeat it. The use of working memory is...

Connie K. Ho for redOrbit.com – Your Universe Online Researchers from Scripps Research Institute recently revealed that a two-drug combination could possibly help those battling cocaine addiction. The combination made up of naltrexone and buprenoprine, two existing pharmaceutical drugs, is a therapy that would help reduce individuals’ want for cocaine and also lessen their feelings of withdrawal. Scientists believed that the therapy is a step forward as there are currently no...

GERMANTOWN, Md., July 24, 2012 /PRNewswire/ -- Psyadon Pharmaceuticals, Inc. announced today that its Phase 2 study of ecopipam in patients with Tourette Syndrome was stopped early when a planned interim analysis revealed a statistically significant reduction in the severity of the patients' tic symptoms. This decision was supported by both the independent Drug Safety and Monitoring Committee overseeing the study and by the external Research Committee established as part of...